European Union - English - EMA (European Medicines Agency)

intervet international bv - live bordetella bronchiseptica bacteria strain b-c2 - immunologicals for felidae, - cats - for active immunisation of cats, of 1 month of age or older to reduce clinical signs of bordetella bronchiseptica associated upper respiratory tract disease.onset of immunity: onset of immunity was established in 8 week old cats as early as 72 hours after vaccination.duration of immunity: the duration of immunity is up to 1 year.no data on the influence of maternal antibodies on the effect of vaccination with nobivac bb for cats are available. from literature it is considered that this type of intranasal vaccine is able to induce an immune response without interference from maternally derived antibodies.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live myxoma vectored rhd virus strain 009, live myxoma vectored rhd virus strain mk1899 - immunologicals for leporidae - rabbits - for active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (rhd) caused by classical rhd virus (rhdv1) and rhd type 2 virus (rhdv2).

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals for canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

European Union - English - EMA (European Medicines Agency)

intervet international bv - leptospira interrogans serogroup canicola serovar portland-vere (strain ca-12-000), l. interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001), l. interrogans serogroup australis serovar bratislava (strain as-05-073), l. kirschneri serogroup grippotyphosa serovar dadas (strain gr-01-005) - immunologicals - dogs - for active immunisation of dogs against:leptospira interrogans serogroup canicola serovar canicola to reduce infection and urinary excretion;l. interrogans serogroup icterohaemorrhagiae serovar copenhageni to reduce infection and urinary excretion;l. interrogans serogroup australis serovar bratislava to reduce infection;l. kirschneri serogroup grippotyphosa serovar bananal / lianguang to reduce infection and urinary excretion.

European Union - English - EMA (European Medicines Agency)

intervet international bv - live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009 - immunologicals - rabbits - for active immunisation of rabbits from five weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease.onset of immunity: 3 weeks.duration of immunity: 1 year.

European Union - English - EMA (European Medicines Agency)

intervet international bv - babesia canis, inactivated, babesia rossi, inactivated - immunologicals for canidae - dogs - for active immunisation of dogs of six months of age or older against babesia canis to reduce the severity of clinical signs associated with acute babesiosis (b. canis) and anaemia as measured by packed cell volume.onset of immunity: three weeks after the basic vaccination course.duration of immunity: six months after the last (re-)vaccination.

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - canine distemper virus, strain onderstepoort; canine adenovirus type 2 strain manhattan lpv3 (live); canine parvovirus strain 154 (live) - lyophilisate and solvent for suspension for injection - . - canine distemper virus + canine adenovirus + canine parvovirus - dogs - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - canine parvovirus attenuated strain 154 - lyophilisate and solvent for suspension for injection - . - canine parvovirus - dogs - immunological - live vaccine

European Union - English - EMA (European Medicines Agency)

virbac s.a. - purified rp-45 felv-envelope antigen - inactivated viral vaccines - cats - active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - canine distemper virus (attenuated); canine parvovirus (attenuated); canine adenovirus type 2 (attenuated) - canine distemper virus (attenuated) 0 vaccine; canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine - vaccine